PRESS RELEASE:
Professor Uwe Reinhardt Welcomes Pharma, Biotech and Device Colloquium Attendees to Princeton University Campus; Colloquium to Feature Advanced Analysis of Research, Payment, Off Label and Risk Management Issues
  • Advanced Executive Education on the Interface of Regulation and Business Strategy for Global Pharmaceutical, Biotechnology and Medical Device Enterprises
  • Offering the Following Categories of Continuing Education Credit: AAPC, ACCME, ACMPE, ACPE, AHIMA, ANCC, CA BRN, CISSP/SSCP, CPHIMS, HCCB, MCLE, NASBA
  • June 6 - 9, 2004
  • Classes Held: McCosh Hall, Princeton University
  • Lodging: Forbes College, Princeton University or Nassau Inn, Princeton, NJ
  • www.PharmaColloquium.com
PRESS RELEASE
Contact: Paul Tunnecliff
800-684-4549 phone
registration@hcconferences.com

PRINCETON NJ USA -- HEALTHCARE UPDATE NEWS SERVICETM -- MAY 13, 2004: The Pharma, Biotech and Device Colloquium, June 6 - 9, 2004, on the campus of Princeton University, www.PharmaColloquium.com, today announced the following:

PROFESSOR UWE REINHARDT WELCOMES COLLOQUIUM ATTENDEES TO PRINCETON:

Uwe E. Reinhardt, Ph.D.
James Madison Professor of Political Economy
Woodrow Wilson School, Princeton University

"It is my pleasure to welcome attendees of the Pharma, Biotech and Device Colloquium to the campus of Princeton University. I hope that you will enjoy this unique experience to contemplate strategic issues in the future of the pharmaceutical, biotechnology and medical device sectors with the assistance of the first rate Colloquium faculty."

SPECIAL ADVANCED COMPLIANCE AND BUSINESS PROCESS SESSIONS OFFERED:
  • The Evolution of the Compliance Program: From Crisis Manager to Business Enabler
  • Getting it Right: Perspectives on Compliance Strategy, Organization and Business Processes
  • Hot Spots in Pharmaceutical, Biotechnology and Device Regulation and Enforcement: What's Next?
  • Taking a Deeper Dive: Regulatory Issues You Should Really Understand - Federal Regulation of Biomedical Research
  • Taking a Deeper Dive: Regulatory Issues You Should Really Understand - Exchange of Scientific Information and Off-label Promotion
  • Taking a Deeper Dive: Regulatory Issues You Should Really Understand - Reimbursement and Payment Update
  • The Role of a Company's Compliance Program in Enhancing the Reputation of the Enterprise
  • The Role of a Company's Compliance Program in Implementing a Program of Enterprise Risk Management
  • Measuring the Effectiveness of a Company's Compliance Program
  • The Special Compliance Challenges of Biopharmaceutical Enterprises
  • The Special Compliance Challenges of Device Manufacturers
  • The Compliance Program of the Future
  • Clinical Development Compliance Issues
  • Manufacturing Compliance Issues
  • Medicare's Quest for Value: Coding, Coverage and Payment
  • Department of Justice Perspective on the Prosecution of Medical Device Companies
  • Legal Trends in Corporate Governance
  • Enterprise Risk Management (ERM) Best Practices from the Board's Perspective; Distinguishing the Role of Board Members from Senior Management
  • Risk Management: What Pharma, Biotech and Device Organizations Can Learn from Other Industries
  • ERM - Making it Happen: In-house Counsel's Role in Designing and Implementing ERM Programs
  • Pharmaceutical, Biotech and Device Sector Regulator Roundtable
  • Law School for Pharmaceutical and Medical Device Manufacturer Executives
  • Developing and Implementing an International Pharmaceutical Compliance Program
  • An Industry Under Regulatory Siege - Why It Happened and What Can Be Done to Correct Misperceptions
  • The Implications of the New Medicare Prescription Drug Legislation for the Pharmaceutical Sector
COLLOQUIUM SPONSORS:
  • AdvaMed
  • Biotechnology Industry Association
  • Harvard Health Policy Review
  • Health Affairs
  • Healthcare Institute of New Jersey
  • National Pharmaceutical Council
  • Pharmaceutical Care Management Association
  • Pharmaceutical Compliance Forum
COLLOQUIUM GRANTORS: KEYNOTE SPEAKERS:

Patricia M. Danzon, Ph.D.
Celia Z. Moh Professor; Professor of Health Care Systems and Insurance and Risk Management, Wharton School, University of Pennsylvania, Author, Pharmaceutical Price Regulation: National Policies vs. Global Interests, Philadelphia, PA

Nancy-Ann DeParle
Senior Advisor, JPMorgan Partners, Former Administrator, Health Care Financing Administration, Washington, DC

Bob Franks
President, Healthcare Institute of New Jersey, Former New Jersey Congressman, Hillside, NJ

Robert S. Galvin, MD, MBA
Director, Global Healthcare, General Electric Company, Founding Member, The Leap Frog Group, Vice Chair, Washington Business Group on Health, Fairfield, CT

Fred Hassan, MBA
Chairman and Chief Executive Officer, Schering-Plough Corporation, Past Chairman, Pharmaceutical Research & Manufacturers of America (PhRMA), Kenilworth, NJ

Pat Kelly
President, US Pharmaceuticals, Vice President, Pfizer Inc., New York, NY

John C. Lechleiter, Ph.D.
Executive Vice President, Pharmaceutical Operations, Eli Lilly and Company, Indianapolis, IN

Peter Leddy
Vice President, Global HR Services, Dell Inc., Round Rock, TX

Mark B. McClellan, MD, PhD
Administrator, Centers for Medicare & Medicaid Services, Washington, DC

Ian Morrison, Ph.D.
Senior Fellow, Institute for the Future, Founding Partner, Harris/Harvard Strategic Health Perspectives, Author, Healthcare in the New Millennium: Vision, Values and Leadership and The Second Curve: Managing the Velocity of Change, Menlo Park, CA

Uwe E. Reinhardt, Ph.D.
James Madison Professor of Political Economy, Woodrow Wilson School, Princeton University, Princeton, NJ

Humphrey Taylor
Chairman, Harris Poll and Harris Interactive, Chairman, National Council on Public Polls, Rochester, NY

The Honorable Tommy Thompson (Invited)
Secretary of Health and Human Services, Department of Health and Human Services, Baltimore, MD

P. Roy Vagelos, MD
Retired Chief Executive Officer and Chairman, Merck & Co., Bedminister, NJ

SPONSORSHIP INFORMATION:

For sponsorship and advertising information review the Promotional Opportunities pages on the Colloquium website: www.PharmaColloquium.com or contact:

REGISTRATION INFORMATION:

For further registration info, call 800-684-4549, email: registration@hcconferences.com, or write:

    Colloquium Office
    7790 Barberry Ave.
    Yucca Valley, CA USA 92284
FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS:

For changes or additions, please email your request to: webmaster@PharmaColloquium.com.

For removal of your e-mail address, please click the "SafeUnsubscribe" link located in the footer of this message below to automatically remove your address from the list.